DARLING INGREDIENTS INC.
DAR
$59.41
-1.82%
Darling Ingredients Inc. is a global developer and producer of sustainable natural ingredients derived from edible and inedible bio-nutrients, serving industries such as pharmaceuticals, food, pet food, animal feed, and renewable energy. The company processes animal by-products into collagen, gelatin, and renewable fuels, positioning itself as a leader in the circular economy within the packaged foods and specialty ingredients sector. Currently, the stock is capturing investor attention due to a remarkable recovery in earnings, driven by robust demand for its feed and food ingredients, as well as a strategic focus on renewable diesel production. The narrative centers on margin recovery and the potential for continued growth in sustainable ingredient solutions, despite historical volatility in commodity-linked segments.…
DAR
DARLING INGREDIENTS INC.
$59.41
Investment Opinion: Should I buy DAR Today?
We rate Darling Ingredients as a Buy, supported by a Strong Buy consensus and a 29.9% upside to the average analyst target of $78.58. The thesis is that the company is in the early stages of a margin recovery, with Q1 2026 showing a 12.6% revenue increase and a dramatic swing to profitability. The forward PE of 10.5x is well below the industry average of 22x, and the price-to-sales ratio of 0.97x is also below the industry average of 1.5x, indicating undervaluation on a forward basis.
Sign up to view all
DAR 12-Month Price Forecast
The AI assessment is bullish, driven by the strong earnings recovery and attractive forward valuation. The key risk is the sustainability of the recovery, given the cyclical nature of the business. If the company can maintain its margin expansion and revenue growth, the stock has significant upside. However, a failure to meet earnings expectations could lead to a sharp de-rating. The stance would be upgraded to high confidence if the next quarter shows continued improvement, and downgraded to neutral if margins contract or revenue growth slows.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DARLING INGREDIENTS INC.'s 12-month outlook, with a consensus price target around $78.58 and implied upside of +32.3% versus the current price.
Average Target
$78.58
0 analysts
Implied Upside
+32.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $90
Analyst target range
Analyst coverage is robust, with 12 analysts providing ratings, and the consensus recommendation is a 'Strong Buy' with a mean rating of 1.25 (where 1 is Strong Buy and 5 is Sell). The average price target is $78.58, implying an upside of approximately 29.9% from the current price of $60.51. The target range spans from a low of $65.00 to a high of $90.00, indicating a wide dispersion in expectations. The high target of $90 suggests that some analysts foresee continued margin expansion and strong demand for renewable fuels, while the low target of $65 reflects caution about potential commodity price volatility. Recent institutional actions have been predominantly positive, with upgrades from Citigroup and reaffirmations of Buy ratings from Jefferies and Stifel, though TD Cowen has maintained a Hold. This bullish sentiment aligns with the strong fundamental recovery and the stock's technical momentum.
Drowning in data?
Find the real signal!
Bulls vs Bears: DAR Investment Factors
Darling Ingredients is showing a powerful earnings recovery, with Q1 2026 net income swinging from a loss to $134.3M and margins expanding significantly. The forward PE of 10.5x is attractive, and analysts are overwhelmingly bullish with a Strong Buy consensus and 29.9% upside to the average target. However, the trailing PE of 94.1x and thin net margin highlight the cyclicality and risk of the business. The most important tension is whether the earnings recovery is sustainable; if it continues, the stock is undervalued, but any setback could lead to a sharp de-rating. Currently, the bull case has stronger evidence given the recent earnings momentum and analyst support.
Bullish
- Strong earnings recovery: Q1 2026 net income surged to $134.3M from a -$26.2M loss a year ago, with EPS of $0.85 vs -$0.16. This dramatic turnaround underscores the success of margin expansion initiatives and improved operational efficiency.
- Margin expansion across the board: Gross margin improved to 17.7% from 13.3% YoY, and operating margin rose to 8.1% from 3.9%. This indicates that the company is successfully passing through costs and benefiting from higher-value product mix.
- Analyst consensus is Strong Buy: With a mean rating of 1.25 (Strong Buy) and an average price target of $78.58, analysts see ~29.9% upside from the current price of $60.51. The high target of $90 implies even greater potential.
- Forward valuation is attractive: The forward PE of 10.5x is well below the industry average of 22x, suggesting the market is pricing in a significant earnings recovery. This offers a compelling risk/reward if earnings materialize as expected.
Bearish
- Trailing PE is extremely high: The trailing PE of 94.1x is far above the industry average of 22x, reflecting that current earnings are still depressed. If the expected earnings recovery stalls, the stock could face significant de-rating.
- Thin net margin: Despite the recent improvement, the trailing twelve-month net margin is only 1.0%. This highlights the cyclical and volatile nature of the business, which could lead to earnings swings.
- High debt levels: The debt-to-equity ratio of 0.88 indicates moderate leverage, but interest expenses of $54.1M in Q1 2026 consume a significant portion of operating income. Rising interest rates could pressure profitability.
- Commodity price exposure: The business is heavily dependent on commodity prices for animal by-products and renewable fuels. A downturn in these markets could quickly reverse the recent margin gains, as seen in the prior year's losses.
DAR Technical Analysis
Darling Ingredients has demonstrated a powerful long-term uptrend, with the stock price surging 102.7% over the past year, significantly outperforming the S&P 500's 21.5% gain. Currently trading at $60.51, the stock sits near the upper end of its 52-week range, at approximately 91.7% of the high of $66.02 and well above the low of $29.15. This positioning near the highs suggests strong momentum and investor confidence, though it also raises the risk of short-term overextension. The stock's beta of 1.02 indicates volatility roughly in line with the broader market, providing a balanced risk profile for investors.
Beta
1.02
1.02x market volatility
Max Drawdown
-22.3%
Largest decline past year
52-Week Range
$29-$66
Price range past year
Annual Return
+93.6%
Cumulative gain past year
| Period | DAR Return | S&P 500 |
|---|---|---|
| 1m | -2.6% | +2.4% |
| 3m | -5.9% | +4.6% |
| 6m | +23.3% | +11.7% |
| 1y | +93.6% | +21.4% |
| ytd | +57.8% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DAR Fundamental Analysis
Darling Ingredients' revenue trajectory has been robust, with the most recent quarter (Q1 2026) reporting revenue of $1.55 billion, a 12.6% year-over-year increase. This growth is supported by a multi-quarter trend: revenue rose from $1.38 billion in Q1 2025 to $1.56 billion in Q1 2026, with sequential growth in the last two quarters. The Feed Ingredients segment is the primary driver, contributing $985.3 million, followed by Food Ingredients at $405.2 million and Fuel Ingredients at $160.3 million. The company's profitability has improved markedly, with net income of $134.3 million in Q1 2026, a significant turnaround from a net loss of $26.2 million in the same quarter last year. Gross margin expanded to 17.7% from 13.3% a year ago, while operating margin improved to 8.1% from 3.9%. Despite this, the trailing twelve-month net margin remains thin at 1.0%, reflecting the cyclical nature of the business. The balance sheet shows a debt-to-equity ratio of 0.88, indicating moderate leverage, and the current ratio of 1.50 suggests adequate liquidity. Free cash flow for the quarter was $58.2 million, and the company generated $153.0 million in operating cash flow, which comfortably covers capital expenditures of $94.8 million. With a return on equity of 1.3% (trailing), profitability is still recovering, but the trend is positive.
Quarterly Revenue
$1.6B
2026-04
Revenue YoY Growth
+12.6%
YoY Comparison
Gross Margin
17.7%
Latest Quarter
Free Cash Flow
$551437000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DAR Overvalued?
Given that Darling Ingredients is profitable, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 94.1x, while the forward PE is much lower at 10.5x, indicating that the market expects a substantial earnings increase in the coming year. This wide gap suggests that the market is pricing in a strong recovery, which is supported by the recent quarterly earnings surge. Compared to the industry average PE of 22x (based on the provided data), Darling's trailing PE is at a significant premium, but the forward PE is at a discount, reflecting the market's anticipation of normalized earnings. The stock's price-to-sales ratio of 0.97x is below the industry average of 1.5x, suggesting that on a sales basis, the stock is undervalued. Historically, the stock's PE has ranged from around 10x to 119x over the past few years, with the current trailing PE near the higher end, but the forward PE is near the lower end, indicating that the market expects a return to more typical earnings levels. The PEG ratio is negative due to the cyclical earnings, but the forward PE suggests reasonable valuation relative to growth.
PE
94.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Darling Ingredients carries a debt-to-equity ratio of 0.88, indicating moderate leverage. Interest expenses of $54.1M in Q1 2026 represent a significant burden, especially if rates rise. The company's net margin is razor-thin at 1.0% on a trailing basis, leaving little room for error. While free cash flow was positive at $58.2M in the quarter, the high capital expenditure of $94.8M suggests ongoing investment needs that could strain cash flows if earnings falter.
FAQ
The key risks include: 1) Commodity price volatility, as the company's margins are sensitive to prices of animal by-products and renewable fuels. 2) High debt levels, with a debt-to-equity ratio of 0.88, which could strain cash flows if interest rates rise. 3) Execution risk in the renewable diesel segment, which is a key growth driver. 4) The cyclical nature of the business, which could lead to earnings swings. The most severe risk is a sharp decline in commodity prices, which could reverse the recent margin gains and cause the stock to fall significantly.
The 12-month forecast for DAR is positive, with a base case target of $78.58 (29.9% upside) and a bull case target of $90 (48.7% upside). The bear case target is $65 (7.4% downside), though the 52-week low of $29.15 represents a worst-case scenario. The most likely scenario is the base case, which assumes continued earnings recovery and stable commodity prices. The probability-weighted expected return is approximately 20% over the next 12 months.
On a trailing basis, DAR appears overvalued with a PE of 94.1x, well above the industry average of 22x. However, on a forward basis, the stock is undervalued with a forward PE of 10.5x, which is below the industry average. The price-to-sales ratio of 0.97x is also below the industry average of 1.5x. This suggests that the market is pricing in a significant earnings recovery, and if that recovery materializes, the stock is undervalued. The wide gap between trailing and forward PE indicates that the market expects a substantial increase in earnings in the coming year.
Yes, DAR appears to be a good buy for investors with a higher risk tolerance. The stock has a Strong Buy consensus from analysts, with an average price target of $78.58, implying a 29.9% upside from the current price of $60.51. The forward PE of 10.5x is attractive relative to the industry average of 22x, and the company is showing strong earnings recovery. However, the trailing PE of 94.1x and the cyclical nature of the business mean that there is significant risk if the recovery stalls. It is best suited for investors who believe the earnings momentum will continue.
DAR is more suitable for long-term investment, given its cyclical nature and the ongoing earnings recovery. The stock has a beta of 1.02, indicating volatility in line with the market, and it has shown strong momentum over the past year. However, the cyclicality means that short-term trading could be risky. A minimum holding period of 2-3 years is recommended to allow the earnings recovery to fully materialize and to ride out commodity price cycles. The company does not pay a dividend, so returns will come from capital appreciation.